These results suggest that the IFN-rich environment in even non-lesional lupus skin promotes photosensitivity by at least in part by causing LC ADAM17 dysfunction and raises the possibility that the beneficial effects of anifrolumab on skin disease in SLE patients reflects the restoration of LC ADAM17 sheddase function. This evidence concerns the gene ADAM17 and systemic lupus erythematosus.